Gd. Shelton et al., Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis, VET IMMUNOL, 78(1), 2001, pp. 97-105
Similar to human autoimmune myasthenia gravis (MG), canine MG occurs sponta
neously and is associated with autoantibodies against the nicotinic acetylc
holine receptor (AChR). In addition to AChR, human MG patients with thymoma
or late-onset MG have antibodies against titin and ryanodine receptor (RyR
). The objective of this study was to establish if dogs with confirmed MG (
AChR antibody titer >0.6 nmol/l) also developed titin and RyR antibodies an
d identify possible associations with thymoma, late age of onset, or severi
ty of clinical signs. Sera from dogs (n = 430) with previously diagnosed au
toimmune MG (N = 415), other immune-mediated neuromuscular disorders includ
ing polymyositis (PM) and masticatory muscle myositis (N = 5), and control
dogs (N = 10) were evaluated for the presence of titin antibodies in ELISA
using MGT-30 as antigen, a peptide representing the main immunogenic region
(MIR) for human titin antibodies. Titin antibody positive sera were furthe
r examined for RyR antibodies in Western blots using a RyR fusion protein (
pc2-RyR) as antigen, which covers the MIR for human MG sera. Titin antibodi
es were found in sera of 80/430 dogs. Thymoma was present in 11/80 and age
of onset was after 4 years in 66/80 titin positive dogs. Two of the titin p
ositive dogs had PM. RyR antibodies were found in 13/80 sera (8/13 thymoma,
12/13 age of onset after 4 years, and 1/13 PM). Neither titin nor RyR anti
bodies were found in sera of healthy control dogs. Acute fulminating MG was
described in five dogs with both titin and RyR antibodies. From these stud
ies we conclude that titin and RyR antibodies in canine and human MG have a
similar association with thymoma, late-onset MG, and possibly with more se
vere forms of MG. (C) 2001 Elsevier Science B.V. All rights reserved.